Literature DB >> 8877315

Unoprostone (isopropyl unoprostone)

M Haria1, C M Spencer.   

Abstract

Unoprostone (isopropyl unoprostone) is a docosanoid compound which is related to a metabolite of prostaglandin (PG)F2 alpha. Unoprostone has oculo-hypotensive effects. The drug is thought to lower intraocular pressure (IOP) by increasing aqueous humour outflow. Aqueous humour production remains unaffected. Marked reductions in IOP have been demonstrated in healthy volunteers and patients with glaucoma or ocular hypertension after instillation of unoprostone 0.12%. Unoprostone 0.12% appears to have similar efficacy to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. In phase II and III clinical studies, adverse events observed with unoprostone were predominantly local; systemic effects occurred less frequently.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877315     DOI: 10.2165/00002512-199609030-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  12 in total

1.  [Ocular penetration of UF-021, a new prostaglandin related compound, in the rabbit eye].

Authors:  C Watanabe; S Matsumoto; K Kin; H Tsuchisaka; R Ueno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-03

2.  [Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy].

Authors:  I Azuma
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1993-02

3.  [The clinical evaluation of UF-021, a new prostaglandin related compound, in low tension glaucoma patients].

Authors:  C Fujimori; S Yamabayashi; M Hosoda; O Hosaka; F Makino; T Henmi; S Tsukahara; R Ueno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1993-10

4.  [Interaction between a prostaglandin F2 alpha derivative, UF-021, and pilocarpine in ocular hypotensive therapy].

Authors:  T Yamamoto; Q Chi; Y Kitazawa
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1994-02

5.  [The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].

Authors:  R Ueno; S Yoshida; T Deguchi; I Kato; T Oda; Y Hayashi; S Kuno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-04

6.  [A mechanism for reducing intraocular pressure in normal volunteers using UF-021, a prostaglandin-related compound].

Authors:  H Tetsuka; H Tsuchisaka; K Kin; Y Takahashi; M Takase
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-04

7.  Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit.

Authors:  M Sakurai; M Araie; T Oshika; M Mori; N Shoji; K Masuda
Journal:  Jpn J Ophthalmol       Date:  1993       Impact factor: 2.447

8.  Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  I Azuma; K Masuda; Y Kitazawa; M Takase; H Yamamura
Journal:  Jpn J Ophthalmol       Date:  1993       Impact factor: 2.447

9.  Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes.

Authors:  M Sakurai; M Araie; T Oshika; M Mori; K Masuda; R Ueno; M Takase
Journal:  Jpn J Ophthalmol       Date:  1991       Impact factor: 2.447

10.  Effect of UF-021 on optic nerve head circulation in rabbits.

Authors:  T Sugiyama; I Azuma
Journal:  Jpn J Ophthalmol       Date:  1995       Impact factor: 2.447

View more
  5 in total

1.  Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone.

Authors:  J Shimazaki; K Hanada; Y Yagi; J Yamagami; M Ishioka; S Shimmura; K Tsubota
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Authors:  A Hommer; B Kapik; N Shams
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 3.  Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Authors:  Carol B Toris; B'Ann T Gabelt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

4.  Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study.

Authors:  Shuichi Yamamoto; Takeshi Sugawara; Akira Murakami; Mitsuru Nakazawa; Nobuhisa Nao-I; Shigeki Machida; Yuko Wada; Yukihiko Mashima; Yozo Myake
Journal:  Ophthalmol Ther       Date:  2012-09-06

5.  Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration.

Authors:  Chieko Shiragami; Masahiro Miyake; Atsushi Fujiwara; Yuki Morizane; Akitaka Tsujikawa; Ayana Yamashita; Fumio Shiraga
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.